Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.33%25.02B | 11.01%6.3B | 16.88%6.43B | 16.17%6.34B | 5.49%5.95B | -5.81%22.27B | -1.70%5.68B | 7.61%5.5B | -9.81%5.46B | -15.98%5.64B |
| Cost of revenue | 10.31%21.2B | -7.50%19.22B | ||||||||
| Gross profit | 25.03%3.82B | 6.40%3.06B | ||||||||
| Operating expense | 33.33%1.71B | 10.28%5.83B | 14.86%5.78B | 17.15%5.89B | 4.96%5.41B | 21.10%1.28B | -2.30%5.29B | 2.13%5.04B | -8.20%5.02B | -14.38%5.15B |
| Selling and administrative expenses | 14.91%1.44B | ---- | ---- | ---- | ---- | -1.91%1.25B | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | 20.83%503.88M | ---- | ---- | ---- | ---- | -9.74%417.02M | ---- | ---- | ---- | ---- |
| -General and administrative expense | 11.95%932.78M | ---- | ---- | ---- | ---- | 2.54%833.21M | ---- | ---- | ---- | ---- |
| Other operating expenses | 21.17%565.36M | 6.84%5.86B | 14.81%5.86B | 16.55%5.89B | 5.68%5.59B | 44.88%466.58M | 1.25%5.49B | 1.85%5.11B | -10.36%5.05B | -16.09%5.29B |
| Total other operating income | -33.04%289.58M | -84.64%30.48M | 11.51%77.47M | ---- | 32.42%183.88M | -19.33%432.46M | 3,174.73%198.42M | -15.46%69.47M | -83.94%25.71M | -51.75%138.86M |
| Operating profit | 19.02%2.11B | 20.93%473.57M | 38.65%648.12M | 4.79%451.45M | 11.17%537.52M | -2.20%1.77B | 7.19%391.59M | 154.80%467.44M | -25.04%430.83M | -29.89%483.5M |
| Net non-operating interest income (expenses) | -7.76%-487.95M | -0.51%-119.06M | -5.85%-123.99M | -15.05%-123.23M | -10.52%-121.67M | -11.61%-452.79M | -14.38%-118.45M | -14.03%-117.13M | -7.49%-107.11M | -10.37%-110.1M |
| Non-operating interest expense | 18.33%255.86M | 0.51%119.06M | 5.85%123.99M | 15.05%123.23M | 10.52%121.67M | 27.38%216.22M | 14.38%118.45M | 14.03%117.13M | 7.49%107.11M | 10.37%110.1M |
| Total other finance cost | -1.89%232.09M | ---- | ---- | ---- | ---- | 0.27%236.58M | ---- | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 14.68%-107.96M | -34.64%-58.57M | -222.15%-1.58M | 35.04%-55.01M | 1,887.57%7.2M | 35.28%-126.53M | -128.02%-43.5M | 122.37%1.29M | 52.06%-84.68M | -93.93%362K |
| Special income (charges) | 89.63%-1.1M | 84.16%-1.59M | -75.49%2.8M | 24.31%-3.28M | 112.82%976K | 82.33%-10.56M | 83.21%-10.05M | 2,784.98%11.44M | -532.73%-4.34M | -1,472.73%-7.61M |
| Less:Write off | -89.63%1.1M | -84.16%1.59M | 75.49%-2.8M | -24.31%3.28M | -112.82%-976K | -82.33%10.56M | -83.21%10.05M | -2,784.98%-11.44M | 532.73%4.34M | 1,472.73%7.61M |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 27.90%1.51B | 34.04%294.35M | 44.71%525.36M | 15.01%269.92M | 15.80%424.02M | 2.71%1.18B | 20.11%219.59M | 387.07%363.03M | -21.64%234.7M | -38.50%366.16M |
| Income tax | 21.27%540.08M | -15.37%142.07M | 47.49%137.41M | 19.16%98.98M | 59.62%161.63M | 175.71%445.36M | 1,095.68%167.87M | 381.95%93.16M | 22.20%83.07M | -10.04%101.26M |
| Net income | 31.90%973.56M | 194.44%152.28M | 43.75%387.95M | 12.73%170.94M | -0.95%262.39M | -25.49%738.13M | -69.36%51.72M | 150.86%269.87M | -34.51%151.64M | -45.13%264.9M |
| Net income continuous operations | 31.90%973.56M | 194.44%152.28M | 43.75%387.95M | 12.73%170.94M | -0.95%262.39M | -25.49%738.13M | -69.36%51.72M | 150.86%269.87M | -34.51%151.64M | -45.13%264.9M |
| Noncontrolling interests | 6.20%156.29M | 25.29%56.32M | 39.31%41.36M | -51.76%16.68M | 10.46%41.93M | -5.93%147.16M | -14.33%44.95M | 26.46%29.69M | -15.10%34.57M | -4.58%37.96M |
| Net income attributable to the company | 38.30%817.28M | 1,318.25%95.96M | 44.30%346.59M | 31.77%154.27M | -2.86%220.46M | -29.16%590.96M | -94.18%6.77M | 185.58%240.18M | -38.65%117.07M | -48.78%226.94M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 38.30%817.28M | 1,318.25%95.96M | 44.30%346.59M | 31.77%154.27M | -2.86%220.46M | -29.16%590.96M | -94.18%6.77M | 185.58%240.18M | -38.65%117.07M | -48.78%226.94M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 36.10%0.739 | 1,333.33%0.086 | 42.01%0.311 | 29.63%0.14 | -4.29%0.201 | -29.84%0.543 | -94.44%0.006 | 180.77%0.219 | -38.98%0.108 | -48.91%0.21 |
| Diluted earnings per share | 36.10%0.739 | 1,333.33%0.086 | 42.01%0.311 | 29.63%0.14 | -4.29%0.201 | -29.84%0.543 | -94.44%0.006 | 180.77%0.219 | -38.98%0.108 | -48.91%0.21 |
| Dividend per share | 0.00%0.6 | 0.2 | 0 | 0.00%0.4 | 0 | -40.00%0.6 | 0 | 0.2 | -50.00%0.4 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.